ERα degrader 7 (compound B1) is a potent ERα degrader with an IC 50 of 14.6 nM and a DC 50 of 9.7 nM, respectively. ERα degrader 7 shows excellent antitumor activity, indicating its potential to evolve as a promising selective estrogen-receptor degrader (SERD) for breast cancer research.